Moderna93W1y9D6FX5mhPTjb9i6rCkTQMjqJrt1en1LTjrHiheA

Moderna Token: A Cautionary Tale of Concentration

Here we observe the cadaver of what was once a promising financial specimen, now expired from acute centralization syndrome. The top ten holders, like vultures circling their prey, have claimed 91.6% of the circulating supply—a concentration so severe it rendered the token fundamentally stillborn. With a mere $61 in daily volume and liquidity of under $4,000, this creature never had a fighting chance; it was dead on arrival, merely waiting for its price to reflect the inevitable.